Sign Out
Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who discontinue entecavir therapy. It is not recommended for administration of entecavir to patient with hiv. Need a dosage adjustment of entecavir for patients with renal disorders (creatinine clearance <50 mL/min, and on hemodialysis).
Use in Children: TKV should not be used in children <16 years.
